Digital Services        F A Q

OTHER VIDEOS

Novel Drug for Cancer Diagnostics and Photodynamic Therapy

228









DEPARTMENT : Department of Chemistry

Novel Drug for Cancer Diagnostics and Photodynamic Therapy
癌症診斷及光動力療法的新型藥物
PRODUCER : Prof. Wong Ka Leung
PROJECT YEAR : 2020
LENGTH : 4 min.
ACCESS : Open to all
SUMMARY : Photodynamic therapy (PDT) is well-known in treating cancer that can selectively kill the cancer cells by utilizing chemical compound called photosensitizer (PS) under a particular light irradiation. This is especially true for cancers like skin cancer, prostate cancer and bladder cancer. Currently, only a few PS drugs for PDT are approved by FDA or under-clinical trials.

In light of an unmet need for PS drugs’ improvement in terms of cancer cell specificity, depth of light penetration and safety, Prof. Wong Ka Leung and his research team have invented a new generation of PS drug, which targets cancer cells specifically. This PS drug is porphyrin-lanthanide complex with specific functional groups which are conjugated with carefully chosen peptides so as to increase cancer cells specificity. The drug is safe as it is used at a lower light energy. It is highly selective and it will only destroy cancer cells instead of normal cells. Therefore, it will not induce adverse effects in patients during and after the treatment.

Besides, it can be used with MRI for early-stage disease diagnosis as it provides high-resolution images for accurate diagnosis of cancer.  
LINK : http://kto.hkbu.edu.hk/



  ●  Persistent link: http://hkbutube.lib.hkbu.edu.hk/ov/display.php?id=10111
  ●  XML Dublin Core code for metadata harvesting
  ●  Go to the full record in the library's catalogue


Recommended for You


This video is presented here with the permission of the producers. Any downloading, storage, reproduction, and redistribution are strictly prohibited without the prior permission of the respective producers. Go to Full Disclaimer.

  For enquiries, please contact Digital and Multimedia Services Section




© 2009-2022 All rights reserved